| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20,618 |
18,774 |
$1.72M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,139 |
18,231 |
$1.17M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,285 |
4,677 |
$729K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,567 |
8,534 |
$674K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,128 |
5,594 |
$531K |
| 80053 |
Comprehensive metabolic panel |
20,339 |
16,466 |
$421K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,058 |
6,094 |
$329K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,039 |
3,715 |
$323K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,380 |
5,595 |
$137K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
970 |
841 |
$113K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,175 |
1,556 |
$89K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,219 |
1,105 |
$88K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
977 |
832 |
$84K |
| 87631 |
|
1,803 |
1,606 |
$75K |
| 81025 |
|
5,086 |
4,584 |
$61K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,327 |
360 |
$60K |
| 36415 |
Collection of venous blood by venipuncture |
25,747 |
18,357 |
$56K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,987 |
1,882 |
$54K |
| G0378 |
Hospital observation service, per hour |
7,460 |
3,133 |
$49K |
| 71045 |
Radiologic examination, chest; single view |
15,270 |
12,987 |
$37K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,989 |
2,133 |
$37K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,170 |
1,851 |
$33K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,046 |
4,260 |
$28K |
| 82948 |
|
6,396 |
2,384 |
$26K |
| 73610 |
|
700 |
617 |
$23K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
659 |
531 |
$21K |
| 73562 |
|
981 |
814 |
$20K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,442 |
2,242 |
$19K |
| 73110 |
|
505 |
443 |
$19K |
| 73630 |
|
804 |
687 |
$19K |
| 73130 |
|
636 |
575 |
$19K |
| 81003 |
|
19,577 |
16,771 |
$18K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,121 |
2,906 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,298 |
1,101 |
$17K |
| 71046 |
Radiologic examination, chest; 2 views |
1,805 |
1,559 |
$17K |
| 72100 |
|
1,378 |
1,076 |
$14K |
| 84484 |
|
12,010 |
6,848 |
$13K |
| 73030 |
|
788 |
640 |
$12K |
| 84703 |
|
3,818 |
3,445 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
565 |
512 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
28,048 |
22,487 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,975 |
3,413 |
$10K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
892 |
746 |
$10K |
| 80047 |
|
1,494 |
1,246 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
15,468 |
12,372 |
$8K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
70 |
55 |
$7K |
| 93971 |
|
643 |
549 |
$7K |
| 70486 |
|
202 |
156 |
$7K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
459 |
425 |
$6K |
| 83880 |
|
3,388 |
2,640 |
$4K |
| A9270 |
Non-covered item or service |
1,807 |
746 |
$4K |
| 85610 |
|
5,314 |
4,097 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,096 |
1,576 |
$3K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,461 |
1,295 |
$3K |
| 73502 |
|
216 |
175 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
72 |
65 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,975 |
4,249 |
$2K |
| 85730 |
|
3,686 |
2,942 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
230 |
198 |
$2K |
| 83735 |
|
4,487 |
3,258 |
$2K |
| 87040 |
|
1,953 |
1,629 |
$2K |
| 84702 |
|
1,016 |
866 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
639 |
604 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
79 |
67 |
$2K |
| 80076 |
|
74 |
61 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,368 |
4,360 |
$2K |
| 82330 |
|
2,397 |
1,968 |
$1K |
| 83690 |
|
6,044 |
5,211 |
$1K |
| 97161 |
|
15 |
12 |
$1K |
| 81001 |
|
420 |
352 |
$1K |
| 73080 |
|
24 |
19 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
537 |
421 |
$1K |
| 87077 |
|
1,615 |
1,364 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,277 |
1,697 |
$1K |
| 12001 |
|
102 |
93 |
$1K |
| 93970 |
|
56 |
51 |
$966.20 |
| 76801 |
|
405 |
341 |
$950.13 |
| 80061 |
Lipid panel |
1,293 |
1,055 |
$905.25 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
629 |
505 |
$889.49 |
| 84145 |
|
467 |
358 |
$889.15 |
| 87186 |
|
1,365 |
1,154 |
$849.23 |
| 83605 |
|
1,170 |
952 |
$827.86 |
| 90715 |
|
597 |
501 |
$662.32 |
| 86900 |
|
685 |
594 |
$645.01 |
| 85380 |
|
1,141 |
1,003 |
$632.66 |
| 12011 |
|
39 |
37 |
$607.59 |
| 85027 |
|
1,996 |
1,415 |
$569.65 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,818 |
1,346 |
$506.57 |
| 76830 |
Ultrasound, transvaginal |
299 |
282 |
$492.01 |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
17 |
13 |
$486.90 |
| J2060 |
Injection, lorazepam, 2 mg |
1,348 |
1,028 |
$416.54 |
| 97162 |
|
60 |
55 |
$323.03 |
| J7050 |
Infusion, normal saline solution, 250 cc |
368 |
234 |
$257.69 |
| 84443 |
Thyroid stimulating hormone (TSH) |
720 |
601 |
$220.70 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
653 |
616 |
$219.96 |
| 72072 |
|
13 |
12 |
$209.16 |
| 74018 |
|
36 |
29 |
$189.95 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
313 |
260 |
$123.41 |
| 90791 |
Psychiatric diagnostic evaluation |
17 |
15 |
$123.29 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
221 |
192 |
$123.29 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,023 |
868 |
$114.28 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
437 |
330 |
$110.33 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
288 |
225 |
$110.24 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
910 |
751 |
$93.07 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
914 |
774 |
$88.51 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
580 |
523 |
$73.34 |
| 87430 |
|
90 |
85 |
$69.36 |
| 86140 |
|
436 |
379 |
$67.61 |
| 29125 |
|
152 |
138 |
$60.99 |
| 87400 |
|
30 |
28 |
$55.86 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
47 |
44 |
$43.64 |
| 86901 |
|
683 |
592 |
$41.84 |
| 87641 |
|
13 |
12 |
$31.58 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
27 |
25 |
$8.44 |
| 84100 |
|
71 |
51 |
$6.66 |
| 82150 |
|
15 |
12 |
$3.88 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
573 |
491 |
$1.30 |
| 73090 |
|
13 |
12 |
$1.16 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
585 |
301 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
445 |
367 |
$0.00 |
| 82140 |
|
45 |
39 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
18 |
12 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
255 |
161 |
$0.00 |
| 87660 |
|
129 |
121 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
19 |
15 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
18 |
15 |
$0.00 |
| 82010 |
|
12 |
12 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
1,296 |
650 |
$0.00 |
| 87510 |
|
129 |
121 |
$0.00 |
| 82077 |
|
179 |
157 |
$0.00 |
| 87480 |
|
129 |
121 |
$0.00 |
| 82550 |
|
182 |
145 |
$0.00 |
| 86850 |
|
67 |
56 |
$0.00 |
| 85652 |
|
14 |
13 |
$0.00 |
| 96376 |
|
25 |
13 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
39 |
37 |
$0.00 |